TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
Uterine arteriovenous malformations – clinical implications
Key Statistics
- <100 — Cases reported in literature
- 0.6–4.5% — Incidence on pelvic USS for AVM
- ≥0.83 m/s — PSV threshold → likely embolisation
Don't-miss facts
-
Suspect uterine AVM in reproductive-age women with unexplained heavy/episodic vaginal bleeding, negative pregnancy test, after delivery/miscarriage/uterine procedure (median 11 months post-intervention)
-
Never perform curettage if AVM suspected – risk of torrential haemorrhage
-
Gold standard investigation: digital subtraction pelvic angiography; spectral Doppler recommended in all women with recurrent heavy bleeding
-
PSV ≥0.83 m/s → likely needs embolisation; PSV <0.39 m/s → embolisation not required
-
Lesion size does not correlate with need for embolisation; haemodynamic status is the main determinant of management
-
UAE is first-line, fertility-sparing, minimally invasive; long-term success 79–92%; hysterectomy reserved for failed embolisation or no fertility wish
-
Post-treatment: menstrual cycle and fertility return to normal in the vast majority; no reported uterine rupture in subsequent labours
-
EMV (postpartum, resolves by 6 weeks) and subinvolution of the placental bed (delayed PPH, USS negative for RPOC) are key differentials, not true AVM
Treatment ladder
Medical: COCP / danazol / GnRH agonist / progestogens
Uterine artery embolisation (first line if bleeding needs transfusion/recurrent)
Hysterectomy: reserved for failed embolisation / no fertility wish
Abbreviation Key
- AVM — arteriovenous malformation
- GTD — gestational trophoblastic disease
- EMV — enhanced myometrial vascularity
- UAE — uterine artery embolisation
- PSV — peak systolic velocity
- PVA — polyvinyl alcohol
- RI — resistance index
- n-BCA — n-butyl cyanoacrylate
- MRI — magnetic resonance imaging
- COCP — combined oral contraceptive pill
- RPOC — retained products of conception
- GnRH — gonadotrophin-releasing hormone
Source: Katimada Annaiah T, Kodakkattil Sreenivasan S. Uterine arteriovenous malformations: clinical implications. The Obstetrician & Gynaecologist 2015;17:243–250. doi:10.1111/tog.12218
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).